Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email